BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Arcato Laboratories Announces Execution of Term Sheet for Series A Round of Financing


5/29/2013 11:30:54 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

GREENSBORO, North Carolina – May 29, 2013 -- Arcato Laboratories, Inc., an emerging oral health company, announced today that it has executed a term sheet with Piedmont Angel Network (PAN), who will lead the company’s Series A round of financing.

Arcato’s lead product is a patented, wax-based medical device that has an over-the-counter anesthetic (benzocaine) incorporated into its matrix to provide sustained relief from the discomfort caused by orthodontic braces.

“We are excited to move forward with Piedmont Angel Network and other private investors to complete the Series A round of funding for Arcato,” said Robert M. Jordan, Chief Executive Officer of Arcato Laboratories. “The Company will use the proceeds of the financing to complete the necessary 510(k) regulatory approval, and then move quickly to launch this product into a marketplace which is sorely in need of a treatment for orthodontic brace pain.”

Based on the frequency of orthodontist visits for brace patients, Arcato estimates a total untapped market for a brace discomfort product to be greater than $400 million per year.

“We are very enthusiastic to lead Arcato’s Series A round of financing,” said Andy Dreyfuss, Fund Executive for Piedmont Angel Network. “PAN is excited about collaborating with an excellent management team that has a solution for a large problem – pain from braces – and that has crafted a strong sales and marketing strategy to capture this market opportunity.”

Arcato is the exclusive licensee of a patent portfolio covering inventions by Dr. Michael Jay, Fred N. Eshelman Distinguished Professor and Chair of the Division of Molecular Pharmaceutics at the University of North Carolina at Chapel Hill. Arcato was founded in 2011 by Dr. Jay and Golden Pine Ventures.

About Arcato Laboratories, Inc.

Arcato Laboratories’ mission is to become a leading oral health company by commercializing unique, proprietary products to serve specialty oral healthcare practitioners, such as orthodontists and oral surgeons. Arcato’s first product will target orthodontists and their patients as the first effective treatment for oral pain caused by orthodontic appliances (braces). Arcato will develop future products by expanding on its current proprietary technology platform, as well as aggressively seeking to create or in-license complementary intellectual property. For more information: www.arcatolabs.com.

About Piedmont Angel Network

The Piedmont Angel Network (PAN) is a committed capital angel fund that focuses on investment opportunities in early-stage companies that present high growth opportunities. PAN has invested in 23 companies since 2002 with a primary focus on the life science, technology, software, and advanced materials fields. While the Fund has a preference to invest in the Piedmont Triad region of North Carolina, PAN has made investments across North Carolina, South Carolina, and Virginia. For more information: www.piedmontangelnetwork.com

Contact:

Robert M. Jordan

Chief Executive Officer

Arcato Laboratories, Inc.

(336) 317-4929



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES